Funding led by TK Partners supports further clinical validation, regulatory preparation, and commercialization of OncoGaze™ SAN DIEGO, April 2, 2026 /PRNewswire/ — Acurion, a precision oncology technology company advancing AI-driven cancer biomarker detection through its OncoGaze™…
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
